goralatide has been researched along with Angiogenesis, Pathologic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bignon, J; Garcia-Alvarez, MC; Kusinski, M; Kuzdak, K; Liu, JM; Riches, A; Wdzieczak-Bakala, J | 1 |
| García-Horsman, JA; Jokinen, B; Männistö, PT; Moreno-Baylach, MJ; Myöhänen, TT; Tenorio-Laranga, J; Vázquez-Sánchez, R | 1 |
| Caers, J; Vanderkerken, K | 1 |
| Bignon, J; Briscoe, C; Ilic, V; Lallemand, JY; Liu, JM; Riches, A; Wdzieczak-Bakala, J | 1 |
1 review(s) available for goralatide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Overexpression of the natural tetrapeptide acetyl-N-ser-asp-lys-pro derived from thymosin beta4 in neoplastic diseases.
Topics: Animals; Biochemical Phenomena; Dipeptides; Mice; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Prolyl Oligopeptidases; Serine Endopeptidases; Thymosin | 2010 |
3 other study(ies) available for goralatide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
Topics: Angiogenesis Inhibitors; Animals; Biocompatible Materials; Collagen; Drug Combinations; Endothelial Cells; Growth Inhibitors; Humans; Kidney; Laminin; Male; Neovascularization, Pathologic; Oligopeptides; Proline; Prolyl Oligopeptidases; Proteoglycans; Rats; Rats, Inbred WF; Serine Endopeptidases; Serine Proteinase Inhibitors; Thymosin; Umbilical Veins | 2011 |
Ac-SDKP: linking cardiac remodeling to hematological malignancies.
Topics: Animals; Growth Inhibitors; Hematologic Neoplasms; Humans; Neovascularization, Pathologic; Oligopeptides; Ventricular Remodeling | 2006 |
Evidence for an association of high levels of endogenous Acetyl-Ser-Asp-Lys-Pro, a potent mediator of angiogenesis, with acute myeloid leukemia development.
Topics: Animals; Bone Marrow; Disease Progression; Growth Inhibitors; Immunoenzyme Techniques; Leukemia, Experimental; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred CBA; Neovascularization, Pathologic; Oligopeptides; Spleen | 2006 |